A 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene written confirmation (7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene WC) is an official document issued by a regulatory agency to a 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene manufacturer, verifying that the manufacturing facility of a 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene APIs or 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene finished pharmaceutical products to another nation, regulatory agencies frequently require a 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene WC (written confirmation) as part of the regulatory process.
click here to find a list of 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene suppliers with Written Confirmation (WC) on PharmaCompass.